M

Moleculin Biotech
D

MBRX

0.28000
USD
-0.08
(-22.11%)
مغلق
حجم التداول
65,178
الربح لكل سهم
-2
العائد الربحي
-
P/E
-0
حجم السوق
14,254,933
أصول ذات صلة الأخبار المقالات

العنوان: Moleculin Biotech

القطاع: Healthcare
الصناعة: Biotechnology
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of resistant tumors and viruses. The company's Annamycin program is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.